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Abstract 
In the last decade, the growth of the pig-farming industry has led to an increase in antibiotic 
use, including several used in human medicine, e.g. (fluoro)quinolones. Data from several 
studies suggest that there is a link between the agricultural use of antibiotics and the prevalence 
of antibiotic-resistant bacteria in the pig farm environment, including (fluoro)quinolone 
resistance. Our goal was to phenotypically and genotypically characterise 174 E. coli showing 
non-susceptibility to quinolones isolated from environmental samples from pig farms. 
Antimicrobial susceptibility testing with nalidixic acid resulted in 16.8% (n=33) intermediately 
resistant and 71.9% (n=141) resistant isolates. Of 174 isolates, 68.4% (n=119) were resistant to 
three or more antibiotics and therefore categorised as multi drug resistant. This study revealed 
a prevalence of 79.9% (n=139) for gyrA QRDR mutations and 21.8% (n=38) isolates with at 
least one PMQR gene. The two most frequently detected PMQR genes were qnrB and qnrS 
with a 13.8% (n=24) and 9.8% (n=17) prevalence, respectively. E. coli with non-susceptibility 
to quinolones are widespread among the environment of Swiss pig farms and are often 
associated with an multidrugresistant phenotype. In several cases these isolates possess at least 
one PMQR gene, which could be spread by horizontal gene transfer. 
 
Keywords: Escherichia coli, antimicrobial resistance, fluoroquinolones, pigs, genotypes 
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Zusammenfassung 
Das Wachstum der Schweinehaltung im letzten Jahrzehnt hat zu einer Zunahme des 
Antbiotikaeinsatzes geführt, inklusive einiger, welche in der Humanmedizin im Einsatz sind, 
z.B. (Fluoro)chinolone. Daten von diversen Studien suggerieren einen Zusammenhang 
zwischen agrarwirtschaftlichem Einsatz von Antibiotika und der Prävalenz von 
antibiotikaresistenten Bakterien im Umfeld von Schweinehaltungen, einschliesslich 
(Fluoro)chinolon Resistenzen. Unser Ziel war die phänotypische und genotypische 
Charakterisierung von 174 E. coli Stämmen, welche Unempfindlichkeit für Chinolone zeigen, 
isoliert aus Umgebungsproben von Schweinefarmen. Antimikrobielle Resistenztests mit 
Nalidixinsäure ergaben 16.8% (n=33) intermediär resistente und 71.9% (n=141) resistente 
Isolate. Von 174 Isolaten waren 68.4% (n=119) resistent gegen drei oder mehr Antibiotika und 
wurden deshalb als multiresistent kategorisiert. Diese Studie ergab eine Prävalenz von 79.9% 
(n=139) für gyrA QRDR Mutationen und 21.8% (n=38) Isolate mit mindestens einem PMQR 
Gen. Die zwei am häufigsten, nachgewiesenen PMQR Gene waren qnrB und qnrS mit jeweils 
13.8% (n=24) und 9.8% (n=17) Prävalenz. E. coli mit einer Unempfindlichkeit für Chinolone 
sind im Umfeld von Schweizer Schweinefarmen weitverbreitet und sind häufig mit einem 
multiresistenten Phänotyp assoziiert. In mehreren Fällen besassen die Isolate mindestens ein 
PMQR Gen, welche durch horizontalen Gentransfer weiterverbreitet werden können. 
 
Schlüsselwörter: Escherichia coli, antimikrobielle Resistenzen, Fluorochinolone, Schweine, 
Genotypen 
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Abstract 
Background: In the last decade, the growth of the pig-farming industry has led to an increase 
in antibiotic use, including several used in human medicine, e.g. (fluoro)quinolones. Data from 
several studies suggest that there is a link between the agricultural use of antibiotics and the 
prevalence of antibiotic-resistant bacteria in the pig farm environment, including 
(fluoro)quinolone resistance. This poses a threat to human and animal health. Our goal was to 
phenotypically and genotypically characterise 174 E. coli showing non-susceptibility to 
quinolones isolated from environmental samples from pig farms. Antimicrobial susceptibility 
testing (AST) was performed using the disk diffusion method. PCR and sequence analysis were 
performed to identify chromosomal mutations in the quinolone resistance-determining regions 
(QRDR) of gyrA and the isolates were screened for the presence of the plasmid-mediated 
quinolone resistance (PMQR) genes aac-69-Ib-cr, qepA, qnrA, qnrB, qnrC, qnrD and qnrS. 
Strain relatedness was assessed by phylogenetic classification and multilocus sequence typing 
(MLST).  
Results: Of 174 isolates, 81% (n=141) were resistant to nalidixic acid, and 19% (n=33) were 
intermediately resistant. Overall, 68.4% (n=119) were multidrug resistant. This study revealed 
a prevalence of 79.9% (n=139) for gyrA QRDR mutations, and detected 21.8% (n=38) isolates 
with at least one PMQR gene. The two most frequently detected PMQR genes were qnrB and 
qnrS (13.8% (n=24) and 9.8% (n=17, respectively). E. coli belonging to phylogenetic group A 
(48.3%/n=84) and group B1 (33.3% /n=58) were the most frequent. E. coli ST10 (n=20) and 
ST297 (n=20) were the most common STs. 
Conclusions: E. coli with non-susceptibility to quinolones are widespread among the 
environment of Swiss pig farms and are often associated with an MDR phenotype. In several 
cases these isolates possess at least one PMQR gene, which could spread by horizontal gene 
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transfer. E. coli from pig farms have diverse STs, some of which are associated with human 
and animal disease.  
Keywords: antimicrobial resistance, fluoroquinolones, pigs, Escherichia coli, genotypes 
 
 
Introduction 
Bacterial diseases in pigs reared on production farms are responsible for high morbidity and 
mortality rates and subsequently also for increased economic losses [1, 2]. The main 
indications for antibiotic therapy in pigs in Switzerland are gastrointestinal and respiratory 
diseases [3]. Therapy may include (fluoro)quinolones, which are categorized by the World 
Health Organization (WHO) as critically important antimicrobial agents (CIAs) [4]. Despite 
the worldwide growth of the pig-farming industry, monitoring systems on the use of 
antibiotics in veterinary medicine have led to reduced antibiotic use in many European 
countries, including Germany, Denmark, The Netherlands, and Sweden [5].  
In pig husbandry, the usual way of drug application is oral, via the feed mixture. This is a 
practical way of drug application from a farmer’s point of view, but the drawback is the 
release of antimicrobial substances into the farm environment [6]. Data from several studies 
suggest that there is a link between the agricultural use of antibiotics and the prevalence of 
antibiotic-resistant bacteria in the pig farm environment, including (fluoro)quinolone 
resistance [7, 8, 9, 10, 11].  
The pathways of antibiotic residues into the environment after animal treatment are numerous. 
Moreover, certain antibiotics such as fluoroquinolones and tetracyclines are not fully 
metabolized in pigs and their residues may be detected in dust, manure, sewage, soil, ground- 
and surface water and crops [6, 12, 13, 14, 15]. These various antibiotic residue reservoirs are 
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perfect breeding grounds for resistant bacteria, including (fluoro)quinolone resistant E. coli 
[16]. During a previous study aimed at analysing the use of fluoroquinolones in Swiss pig farms 
(von Ah, et al., manuscript under review), quinolone non-susceptible E. coli were isolated from 
environmental samples (dust, liquid manure and wipe samples of bay walls) of the farms. The 
goal of this study was to characterize these isolates with regard to the two main mechanisms of 
(fluoro)quinolone resistance in Enterobacteriaceae, i.e., the accumulation of mutations in the 
Quinolone Resistance Determining Region (QRDR) of gyrA encoding DNA gyrase, and the 
acquisition of plasmid-mediated quinolone resistance (PMQR) genes [11]. A further aim was 
to characterize the strains by phylogenetic grouping and multilocus sequence typing (MLST).  
 
 
Material & Methods 
Strains & data collection 
In this study, we analysed 174 E. coli isolates collected during 2016 by the Division of Swine 
Medicine of the Vetsuisse Faculty Zurich (von Ah, et al., manuscript under review). The 
collection consisted of strains obtained using both qualitative and semi quantitative methods 
to isolate quinolone resistant E. coli from dust, wipe and slurry samples from farm 
environments. For the qualitative method, an average of 1.91 g of sample was diluted 1:10 in 
Enterobacteriaceae Enrichment (EE) broth (Becton, Dickinson, Heidelberg, Germany) and 
incubated at 37°C overnight. The enrichment was then spread on RAPID'E. coli agar (Biorad, 
Munich, Germany), supplemented with 8 μg/ml nalidixic acid, and incubated overnight at 
37°C. Using the semi-quantitative approach, an average of 1.97 g of sample, were diluted in a 
ratio of 1:10 in 0.85% saline solution and homogenized in a Stomacher sample blender 
(Seward Medical Ltd., London, UK). The homogenate was spread in dilution steps of 1:100 
and 1:1000, respectively, on RAPID'E. coli agar plates supplemented with 8 μg/ml nalidixic 
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acid. One E. coli isolate randomly selected from each positive sample was collected for 
further analysis. Isolates with questionable identity on RAPID'E. coli agar were confirmed by 
matrix-assisted laser desorption/ionization time-of- flight mass spectrometry (MALDI-TOF–
MS, Bruker Daltronics, Bremen, Germany). 
In total, the strains originated from dust (n=48), wipes (n=56), and slurry (n=70), collected 
from 55 different farms (24 farrowing and rearing farms, 23 fattening farms and 8 mating and 
gestation farms) located in central and north-eastern Switzerland. All farms were part of a sow 
pool system. Of the 55 farms, 23 (41.8%) reported use of fluoroquinolones during the study 
period of 2016, including 16 (66.7%) of the farrowing and rearing, four (17.4%) of the 
fattening, and three (37.5%) of the mating and gestation farms. 
 
Microbiological methods 
Antimicrobial susceptibility testing 
The antimicrobial resistance profiles of the isolates were determined using the disk diffusion 
(Kirby Bauer) method according to the Clinical and Laboratory Standards Institute (CLSI) 
performance standards and breakpoints for human clinical isolates [17]. Mueller-Hinton agar 
culture medium (Becton Dickinson, Allschwil, Switzerland) was inoculated with a saline 
suspension of isolated colonies adjusted to 0.5 McFarland turbidity standard. Antibiotic disks 
(Becton Dickinson and company, Sparks, MD USA) were used, containing 30 µg nalidixic acid 
(NA), 5 µg ciprofloxacin (CIP), 10 µg ampicillin (AM), 20 µg/10 µg amoxicillin/clavulanic 
acid (AMC), 30 µg cefazolin (CZ), 30 µg cefotaxime (CTX), 30 µg cefepime (FEP), 23.75 µg 
/1.25 µg sulfamethoxazole/trimethoprim (SXT), 30 µg chloramphenicol (C), 15 µg 
azithromycin (AZM), 30 µg tetracycline (TE), 10 µg streptomycin (STR), 30 µg kanamycin 
(K), 10 µg gentamicin (GM), 300 µg nitrofurantoin (FM), and 200 µg fosfomycin (FOS). After 
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18 h of incubation at 35°C±2°C, results were interpreted as either sensitive (S), intermediate 
(IR), or resistant (R) according to the zone diameters around the disks using CLSI breakpoints 
[17]. Results were confirmed to be within the quality control ranges described by CLSI for E. 
coli ATCC25922 [17].  
Isolates displaying resistance to three or more classes of antimicrobials (counting β-lactams as 
one class) were defined as multidrug-resistant (MDR). 
 
Molecular methods 
Analysis of the quinolone resistance-determining region (QRDR) in gyrA 
All strains were examined for mutations in the quinolone resistance-determining regions 
(QRDRs) of gyrA, using PCR amplification and sequencing primers as described previously 
[18]. Synthesis of primers and DNA custom sequencing was carried out by Microsynth 
(Balgach, Switzerland). Nucleotide sequences were analyzed with CLC Main Workbench 
8.0.1 and aligned with the sequence gyrA reference strain E. coli K-12, substrain MG1655 
(GenBank: U00096). For database searches the BLASTN program of the National Centre for 
Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/blast/) was used.  
Detection of plasmid mediated quinolone resistance genes (PMQR) 
The plasmid-mediated fluoroquinolone resistance genes aac(6')-Ib-cr, qnrA, qnrB, qnrC, qnrD, 
qnrS, and qepA were detected by PCR as described elsewhere [19, 20, 21, 22, 23, 24, 25]. 
Synthesis of primers and DNA custom sequencing was carried out by Microsynth (Balgach, 
Switzerland) and nucleotide sequences were analyzed with CLC Main Workbench 8.0.1. In 
addition, qnrB and qnrS genes were sequenced. 
The presence of qnrB was confirmed by PCR as described by Abgottspon et al., using strain 
N05-2379 as a positive control [26]. Purified amplicons were custom sequenced (Microsynth, 
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Balgach, CH) using the forward primer (qnrB_Seq_F) [26]. Sequences were analysed using the 
Basic Local Alignment Search Tool (BLAST) of the NCBI 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Bethesda, USA). 
The presence of qnrS confirmed and sequenced as described by Zurfluh et al., using E. coli 
OW95E1 as a positive control and the forward primer (qnrS_orf_F) [27]. Sequences were 
analysed as described for qnrB. 
Phylogenetic characterization and multilocus sequence typing 
Phylogenetic classification of the E. coli isolates into one of the eight groups A, B1, B2, C, D, 
E, F, or (E. coli sensu stricto), or Escherichia clade I, was performed as described by Clermont 
et al. [28].  
Sequence type (ST) determination of the E. coli isolates was carried out as described by Wirth 
et al. [29]. Sequences were imported into the E. coli multilocus sequence type (MLST) 
database (http://enterobase.warwick.ac.uk) to determine MLST types and clonal complexes 
(CC). 
Serotyping of E. coli ST301 
Strains belonging to CC165 and ST301 frequently belong to the unusual O80 serogroup [30]. 
To test this possibility, all isolates belonging to ST301 were serotyped. The O80 serogroup 
was identified by O80-specific PCR using primers and conditions described previously [30]. 
The H2 type was determined by PCR targeting the flicH2 gene with primers described 
elsewhere [31]. The presence of the intestinal virulence genes stx, eae and of extra-intestinal 
virulence genes associated with plasmid pS88 [32] was evaluated as described previously 
[33]. 
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Results 
Antimicrobial resistance phenotypes 
Antimicrobial susceptibility testing by the disc diffusion method showed that 81% (n=141) of 
the strains were resistant and 19% (n=33) were intermediately resistant to nalidixic acid (Table 
1). Furthermore, 36.2% (n=63) of the isolates were also resistant to ciprofloxacin (Table 1). 
Additional antimicrobial resistance was most frequently observed for streptomycin (72.4% 
/n=126), tetracycline (60.9% /n=106), sulfamethoxazole/trimethoprim (50% /n=87), ampicillin 
(46.6% /n=81), kanamycin (19.5% /n=34), chloramphenicol (15.5% /n=27), and gentamicin 
(14.4% /n=25), respectively (Table 1). Resistance to all other tested antibiotics was detected for 
at least one isolate, except to nitrofurantoin (Table 1).  
Of the 174 isolates analysed in this study, 68.4% (n=119) were resistant to three or more classes 
of antibiotics and therefore categorised as MDR. The most frequent MDR combinations 
detected were SXT-TE-STR (n=15), AM-SXT-TE-S (n=10) and AM-SXT-STR-K (n=8) 
(Table 1). E. coli strains resistant to four and five antibiotics were the most prevalent (21.3% 
and 19.0%, respectively). 
Molecular properties 
Of 141 isolates with a nalidixic acid resistant phenotype, 98.6% (n=139) possessed at least one 
nucleotide mutation in the QRDR of gyrA. Thereof, 49.6% (n=70) showed single amino acid 
substitution at codon Ser83, namely Ser83 to Leu (n=67), or Asp87 to Tyr (n=2), or Asp87 to 
Gly (n=1). Further, 48.9% (n=69) possessed double substitutions at Ser83 to Leu and Asp87 to 
Asn (n=68) or Tyr (n=1). Two isolates (isolates no. 65 and 106, respectively) tested negative 
for mutations in the QRDR of gyrA (Table 1). 
A total of 38 strains possessed one or more PMQR genes, representing 21.8% of the 174 
analysed strains (Table 1). Among the 19.5% (n=34) of the isolates with one PMQR gene, 
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twenty (11.5%) possessed qnrB, thirteen (7.5%) qnrS and one isolate (0.6%) possessed aac(6’)-
Ib, respectively (Table 1). Four isolates (2.3%) possessed a combination of qnrB and qnrS 
genes. No isolates tested positive for qnrA, qnrC, qnrD or qepA. The occurrence of PMQR 
positive isolates was remarkably higher in strains exhibiting intermediate resistance to nalidixic 
acid (90.9% /n=30), than in nalidixic acid resistant strains (5.7% /n=8). Moreover, all qnrB/qnrS 
combinations were detected in intermediately resistant isolates (Table 1). Isolates possessing 
PMQR were found in 11 (22.9%) of the dust samples 16 (28.6%) of the wipe samples. and 11 
(15.7%) of the slurry samples (Table 1).  
Of the 23 farms with reported use of fluoroquinolones, 12 (52.2%) yielded environmental E. 
coli containing PMQR genes. Thereof, the majority (7 farms/58.3%) were farrowing and 
rearing farms, three (25%) were fattening farms and two (16.7%) were mating and gestation 
farms (Table 1). 
By contrast, of the 32 farms without a history of fluoroquinolone use during the study period, 
nine (28.1%) tested positive for E. coli harbouring PMQR genes. Thereof, five (55.6%) were 
fattening farms, four (44.4%) were mating and gestation farms, and none (0%) were farrowing 
and rearing farms (Table 1). 
Phylogenetic grouping 
The majority of the isolates were assigned to phylogenetic groups A (48.3%/n=84) and group 
B1 (33.3% /n=58). The remaining strains were classified into group C (9.8% /n=17), E 
(6.9%/n=12), F (1.1%/n=2) and D (0.6%/n=1), respectively (Table 1). None of the isolates 
belonged to phylogenetic group B2. 
MLST 
Overall, a total of 50 STs were found. The most common sequence types were ST10 (n=20), 
ST297 (n=20), ST453 (n=10), ST88 (n=9), ST898 (n=8), ST93 (n=6), ST2197 (n=6), ST737 
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(n=5), and ST2509 (n=5) (Table 1). Seven isolates could not be assigned to any known ST, 
because the allele combinations were new (Table 1). The allele combinations are listed in 
supplementary Table S1. 
Characteristics of E. coli ST301 isolates 
Three isolates belonged to ST301 (Table 1). Thereof, two (isolates 30 and 31, respectively) 
belonged to serotype O80:H2 and possessed the eae-ξ variant. None of the isolates harboured 
stx or any genes related to pS88. Both isolates were therefore classified as enteropathogenic E. 
coli (EPEC). 
 
 
Discussion 
Resistance profiles 
In the present study, we determined the prevalence of point mutations within the QRDR of gyrA 
and the presence of PMQR genes among 174 E. coli isolated from pig farm environments. All 
isolates were non-susceptible to quinolones and, using the disk diffusion method, were 
classified as intermediate or as resistant to nalidixic acid.  
All resistant isolates except two, possessed at least one mutation in gyrA. Notably, both these 
isolates possessed a PMQR gene, (isolate 65 possessed qnrB, and isolate 106 qnrS, 
respectively). Since qnr genes alone are insufficient to confer resistance [34, 35, 36], further 
mechanisms are likely associated with the resistance phenotype of these strains, such as 
mutations in the QRDR regions of the gyrB, parC genes, or increased efflux pump activity 
(both not evaluated in this study).  
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Of the 70 nalidixic acid resistant strains possessing one mutation in gyrA, only one (0.7%) was 
resistant to ciprofloxacin. By contrast, of the isolates with double mutations in gyrA, the 
majority (89.9%) were also resistant to ciprofloxacin. These observations correlate with 
previous studies that link the number of quinolone resistance-associated mutations and the 
resistance phenotype of an isolate [37, 38].  
In this study, only a minority of the resistant strains carried PMQR genes, and, except for 
aac(6’)-Ib-cr, none of the PMQR genes were associated with ciprofloxacin resistance. Isolates 
with qnrS also possessed a S83L substitution in the gyrA QRDR and showed decreased 
susceptibility to ciprofloxacin. Two further resistant isolates harbouring qnrS or qnrB lacked 
mutations in the gyrA QRDR and were susceptible to ciprofloxacin. In short, these data correlate 
with results from previous studies on the coexistence of different resistance mechanisms in one 
isolate [37, 38, 39]. 
Notably, the vast majority (90.9%) of strains with intermediate resistance to nalidixic acid were 
associated with the presence of qnrB, qnrS or a combination thereof. The three remaining 
intermediately resistant isolates lacking both gyrA mutations and aac(6')-Ib-cr, qnrA, qnrB, 
qnrC, qnrD, qnrS, or qepA genes,  are likely to possess other resistance-mechanisms that we 
did not screen for in the present study, e.g., point mutations within the QRDR of gyrB or in the 
topoisomerase genes parC or parE [11]. Four isolates possessed a combination of qnrB and 
qnrS genes but remained intermediately resistant to nalidixic acid. These results are in 
agreement with the findings of other studies [40, 41], which demonstrate that the presence of 
two different qnr genes in the same strain has no additive effect on resistance levels. Further, 
our data correlate with previously mentioned studies concerning the coexistence of different 
resistance mechanisms in one isolate [37, 38, 39]. 
The predominance of PMQR among isolates that lack gyrA mutations is noteworthy, since these 
genes are known to facilitate the selection of resistant mutants. Data from other studies [47, 48] 
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suggest that, depending on which mutations are already present in a strain, the acquisition of 
further fluoroquinolone resistance genes could increase the strain’s fitness.  
In this study, the most frequent PMQR genes were qnrB and qnrS, respectively. Correlating 
with our data, it has been reported previously that qnrB is the most frequent PMQR gene, 
followed by qnrS. [11, 36, 44, 45]. The presence of qnr genes in environmental E. coli indicates 
that selection could occur without exposure to inhibitory concentrations of fluoroquinolones. It 
has been demonstrated previously for environmental Klebsiella pneumoniae isolated from 
wastewater that qnr genes confer a selective advantage in the presence of residual subinhibitory 
fluoroquinolone concentrations present in wastewater [46] Accordingly, pig farms with a 
history of (in-feed) application of fluoroquinolones may represent environments containing 
residual concentrations of antibiotics which propagate PMQR genes. Our data suggest that this 
may hold true in particular for farrowing and rearing farms, where such genes were detected 
exclusively on farms with a history of use of fluoroquinolones. Environmental pollution with 
residual fluoroquinolones is facilitated by their poor degradability and strong potential for 
binding to sediments [47]. In the absence of solar radiation some fluoroquinolones 
(enrofloxacin) remain stable for at least 120 days [48]. In their long-term experimental study 
Xu and colleagues [49] stated that the application of swine manure lead to an increase of 
fluoroquinolone resistances in soil, including PMQR genes, which persisted at least five 
months. On farms without prior treatment of animals, strains harbouring quinolone resistance 
genes may be introduced during transfer of pigs from other locations, comparable to inter-farm 
transmissions of extended-spectrum ß-lactamase (ESBL) producing E. coli in pigs [50]. Our 
data suggest that this may especially be the case for mating and gestation farms and for fattening 
farms, where, in contrast to farrowing and rearing farms, environmental contamination with E. 
coli harbouring PMQR genes was detected irrespective of the history of fluoroquinolone 
treatment. These findings suggest that animal movement to and from farrowing and rearing 
 18 
farms with recent histories of treatment, may promote the risk of transmission of resistant 
bacteria and of fluoroquinolone resistance genes among farms within sow pool systems. 
Apart from direct transmission of resistant E. coli, PMQR genes can be transferred horizontally 
to other bacteria in the pig farm environment. Exposure to quinolones of bacteria containing 
qnr genes may increase their capacity to acquire point mutations in the gyrase and/or 
topoisomerase IV genes [46]. PMQR genes are often harboured on plasmids containing other 
resistance genes, e.g., ß-lactamases, [51] thus, the use of non-fluoroquinolone antimicrobials 
enables their co-selection [52].  
Overall, the resistance profiles of the isolates described in this study are in agreement with 
previous studies that have demonstrated that some of the most common antibiotic resistances 
(other than quinolones) in E. coli in the pig environment are tetracycline, ampicillin, 
streptomycin and sulfamethoxazole [53, 54], and that E. coli strains from the pig environment 
often are resistant to four or five antibiotics simultaneously [55]. 
 
Phylogenetic grouping, MLST and serotyping of ST301 
The majority of the isolates belonged to phylogenetic groups A or B1. The predominance of 
ST10 among the E. coli belonging to group A reflect previous observations regarding isolates 
from pigs, chicken feces, as well as retail chicken and pork meat [56, 57]. Furthermore, 
Araùjo et al. [58] observed that E. coli ST10 and ST297 were the predominant sequence types 
among MDR isolates isolated from irrigation water and vegetables in household farms, 
highlighting the wide dissemination of this sequence type and its association with MDR. 
Notably, E. coli ST10 (CC10), as well as E. coli CC23 also identified in this study, both 
including ciprofloxacin resistant and MDR strains, are also associated with urinary tract 
infection and sepsis in humans [59].  
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In addition, several other E. coli belonging to phylogenetic group A identified in this study 
have been associated with disease in food producing animals, such as avian pathogenic E. coli 
ST93 [60], E. coli ST744 isolated from diseased calves [61], and strains belonging to CC165 
from food producing animals [62]. Notably, among the latter, we detected two EPEC O80:H2 
isolates, which is considered an emerging pathogen among calves in Belgium [63]. This 
serotype has emerged among humans as a highly virulent extra-intestinal pathogenic Shiga-
toxin producing E. coli (STEC) in France and Switzerland since 2015 [30, 33]. As opposed to 
the STEC O80:H2 found in humans, the isolates from this study lacked pS88-associated 
extra-intestinal virulence genes. Therefore, the relationship between EPEC O80:H2 isolated 
from the farm environment and human STEC isolates needs to be assessed e.g. by whole 
genome sequencing, and the prevalence of EPEC O80:H2 in pigs should be established. 
E. coli strains belonging to the phylogenetic group B1 are for the most part commensal, with 
the ability to persist in the environment [64]. Most ST of this phylogroup, such as ST58, 
ST162, or ST453 have been frequently detected among healthy livestock [65]. However, E. 
coli ST297, which was one of most frequently observed ST in this study, has been associated 
with disease in both poultry and humans [66]. Likewise, E. coli ST453 is known to cause 
extraintestinal disease in humans (urinary tract infections) and metritis in cattle [67].  
A minority of strains were assigned to the extraintestinal virulent phylogroups D and F. 
Among these, we detected two MDR strains belonging to ST117 which is a well-recognized 
avian pathogenic E. coli with zoonotic potential [68].  
 
Conclusions 
Quinolone non-susceptible E. coli are widespread in the environment of Swiss pig farms. In 
particular, isolates showing intermediate resistance to nalidixic acid frequently possess 
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transmissible PMQR genes. This is worrisome, since the presence of qnr genes may increase 
the ability of bacteria to acquire point mutations in the gyrase and topoisomerase IV genes, 
resulting in high level resistance to (fluoro)quinolones. Furthermore, plasmids harbouring qnr 
genes may contribute to the horizontal spread of antibiotic resistance in livestock and in the 
environment. In pig farms which are part of sow pool systems, inter-farm measures that aim to 
reduce the risk of spreading resistant bacteria and resistance genes from one stage of production 
to the next need to be assessed and promoted. Our data further show that farm environments 
contain commensal MDR E. coli as well as E. coli with zoonotic potential. In particular, we 
demonstrate for the first time the presence of EPEC O80:H2 in an environmental sample from 
a pig farm. 
In order to preserve the usefulness of fluoroquinolones and to protect animal and human 
health, surveillance of antimicrobial resistance is warranted. Measures for prudent use of 
(fluoro)quinolones as provided by the European Union’s guidelines for use of antimicrobials 
in veterinary medicine are of utmost importance [69]. 
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Table 1: Escherichia coli isolated from dust, wipes and slurry samples from pig farms. 
Isolate 
ID 
Farm 
ID 
Farm 
type 
FQ 
usage 
Source NA CIP QRDR  
gyrA 
PMQR gene PG ST CC Additional resistance 
19 11 F&R + D R IR S83L, D87N –– B1 453 86 AM, SXT, TE, STR, GM 
45 12 F&R + D R R S83L, D87N –– B1 162 469 AM, SXT, TE, STR, K 
22 13 F&R + D R R S83L, D87N –– B1 1642 –– AM, SXT, C, TE, STR, K, GM 
28 13 F&R + D R R S83L, D87N –– B1 1642 –– AM, SXT, C, TE, STR, K, GM 
40 17 F&R + D R R S83L, D87N –– A 10 10 AM, SXT, C, TE, STR 
44 17 F&R + D R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR, K, GM 
8 18 F&R + D R R S83L, D87N –– A 2197 –– AM, SXT, AZM, C, TE, STR, K, GM 
9 18 F&R + D R R S83L, D87N –– A 2197 –– AM, CTX, SXT, AZM, C, TE, STR, 
K, GM 
54 21 F&R + D R R S83L, D87N –– A 2197 –– AM, SXT, C, TE, STR, GM 
55 21 F&R + D R S S83L –– B1 345 –– AM, SXT, STR, K 
117 22 F&R + D R S S83L –– C 90 23 –– 
126 23 F&R + D R S S83L –– A 898 –– TE 
127 23 F&R + D R S S83L –– A 898 –– –– 
129 23 F&R + D R S S83L –– A 898 –– –– 
62 29 F&R + D R R S83L, D87N aac(6’)-Ib-cr C 6332 –– AM, AMC, CZ, CTX, FEP, SXT, 
AZM, TE, STR, GM 
149 29 F&R + D IR S –– qnrS A 542 –– SXT, TE, STR 
66 30 F&R + D R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR, K, GM 
160 30 F&R + D IR S –– qnrB A new –– AM, SXT, TE, STR 
168 30 F&R + D IR S –– qnrB A 34 10 TE, STR 
169 30 F&R + D IR S –– qnrB A 43 10 –– 
2 71 F&R + D R R S83L, D87N –– B1 297 –– AM, AMC  
11 71 F&R + D R S S83L qnrS A 2496 –– AM, AMC, STR 
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Isolate 
ID 
Farm 
ID 
Farm 
type 
FQ 
usage 
Source NA CIP QRDR  
gyrA 
PMQR gene PG ST CC Additional resistance 
145 71 F&R + D IR IR –– qnrS A 301 165 SXT, TE, STR 
107 73 F&R + D R S S83L –– A 10 10 AM, C, TE, STR 
109 73 F&R + D R S S83L –– A 898 –– TE, STR 
97 69 FF + D R R S83L, D87N –– B1 297 –– TE 
173 69 FF + D IR S –– qnrB E 1607 –– –– 
113 1 M&G + D R S S83L qnrS A 10 10 AM, SXT, STR 
164 1 M&G + D IR S –– qnrS A new –– AM 
13 6 M&G + D R S S83L –– B1 737 –– SXT, TE, STR 
14 6 M&G + D R S S83L –– B1 737 –– SXT, TE, STR 
41 17 F&R + W R R S83L, D87N –– B1 58 155 AM, SXT, TE, STR 
125 22 F&R + W R S S83L –– A 4691 –– STR 
56 23 F&R + W R S S83L –– A 1684 –– SXT, STR 
128 23 F&R + W R S S83L –– C 410 23 TE, STR, K 
59 26 F&R + W R S S83L –– E 302 –– AM, STR 
139 26 F&R + W R S S83L –– E 302 –– AM, STR 
65 29 F&R + W R S –– qnrB E 1607 –– SXT, AZM, STR 
161 29 F&R + W IR S –– qnrB E 1607 –– –– 
67 30 F&R + W R S S83L –– A 746 –– SXT, TE, STR 
141 30 F&R + W R S S83L –– E 302 –– –– 
143 30 F&R + W IR S –– –– E 302 –– –– 
150 30 F&R + W IR S –– qnrB A 10 10 SXT, FM, STR 
3 71 F&R + W R S S83L –– A 542 –– –– 
12 71 F&R + W R IR S83L qnrS A 2496 –– AM, CZ, STR 
137 71 F&R + W R S D87G –– A 3630 –– –– 
144 71 F&R + W IR IR –– qnrS E new –– AM, SXT, TE, STR 
99 73 F&R + W R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR 
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Isolate 
ID 
Farm 
ID 
Farm 
type 
FQ 
usage 
Source NA CIP QRDR  
gyrA 
PMQR gene PG ST CC Additional resistance 
101 73 F&R + W R S S83L –– A 898 –– SXT, TE, STR 
102 73 F&R + W R S S83L –– A 1684 –– SXT, TE, STR 
106 73 F&R + W R S –– qnrS A 871 –– SXT, TE, STR 
123 73 F&R + W R S S83L –– B1 3695 –– –– 
155 74 F&R + W IR S –– –– C 23 23 TE, STR, K 
119 38 FF + W R S S83L –– A 100 165 SXT, TE, STR 
152 53 FF + W IR S –– qnrB + qnrS E new –– AM10, SXT, TE, STR 
146 59 FF + W IR S –– qnrB + qnrS A 10 10 AM, SXT, TE, STR, K, GM 
132 69 FF + W R S S83L, D87N –– B1 297 –– SXT, TE, STR 
163 1 M&G + W IR S –– qnrB A 34 10 TE, STR 
157 4 M&G + W IR S –– qnrB A 1602 –– STR 
158 4 M&G + W IR S –– qnrB A new –– STR 
115 6 M&G + W R S S83L –– D 362 –– AM, SXT, C, TE, STR, K 
124 6 M&G + W R S S83L –– A 93 168 AM, SXT, FOS, STR 
20 12 F&R + SL R IR S83L, D87N –– B1 297 –– TE 
21 12 F&R + SL R IR S83L, D87N –– B1 297 –– TE 
27 12 F&R + SL R IR S83L, D87Y –– A 10 10 –– 
23 13 F&R + SL R S D87Y –– A 34 10 STR 
24 13 F&R + SL R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR, K, GM 
29 13 F&R + SL R S D87Y –– A 34 10 STR 
30 13 F&R + SL R S S83L –– A 301 165 SXT, STR 
31 13 F&R + SL R S S83L –– A 301 165 SXT, AZM, STR 
25 16 F&R + SL R S S83L –– A 10 10 –– 
26 16 F&R + SL R R S83L, D87N –– B1 297 –– FOS, TE 
42 16 F&R + SL R R S83L, D87N –– B1 297 –– TE 
116 16 F&R + SL R S S83L –– A 10 10 –– 
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Source NA CIP QRDR  
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165 16 F&R + SL R R S83L, D87N –– B1 297 –– TE 
38 17 F&R + SL R R S83L, D87N –– B1 297 –– –– 
39 17 F&R + SL R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR, GM 
43 17 F&R + SL R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR, K, GM 
156 18 F&R + SL IR S –– qnrB A 77 206 AM10, SXT, C, STR 
166 21 F&R + SL IR S –– qnrB A 10 10 SXT, STR 
118 26 F&R + SL R S S83L –– A 6593 165 STR 
130 28 F&R + SL R S S83L –– A 93 168 –– 
136 28 F&R + SL R S S83L –– A 93 168 –– 
167 28 F&R + SL IR S –– qnrS A 48 10 AM, TE, STR 
63 29 F&R + SL R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR 
64 29 F&R + SL R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR 
4 71 F&R + SL R R S83L, D87N –– A 3902 –– AM, SXT, TE, STR 
5 71 F&R + SL R IR S83L qnrS A 2496 –– AM, CTX, FOS, AZM, STR 
6 71 F&R + SL R IR S83L, D87N –– B1 162 469 AM, SXT, TE, STR, K 
7 71 F&R + SL R R S83L, D87N –– B1 162 469 AM, SXT, TE, STR, K 
10 71 F&R + SL R IR S83L qnrS A 2496 –– AM, STR 
100 73 F&R + SL R S S83L –– A 10 10 AM, C, TE, STR 
108 73 F&R + SL R S S83L –– A 10 10 AM, C, TE, STR 
122 73 F&R + SL R S S83L –– A 10 10 AM, C, TE, STR 
85 53 FF + SL R R S83L, D87N –– B1 162 469 STR 
96 69 FF + SL R R S83L, D87N –– B1 297 –– TE 
1 1 M&G + SL R S S83L –– B1 156 156 SXT, STR 
15 6 M&G + SL R R S83L –– B1 737 –– SXT, TE, STR 
114 6 M&G + SL R S S83L –– B1 737 –– SXT, TE, STR 
135 6 M&G + SL R S S83L –– A 93 168 –– 
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34 14 F&R - D R R S83L, D87N –– E 1011 –– AM 
35 14 F&R - D R R S83L, D87N –– E 1011 –– AM 
49 20 F&R - D R R S83L, D87N –– A 744 –– AM, SXT, C, TE, STR, K, GM 
53 20 F&R - D R IR S83L, D87N –– A 2197 –– AM, SXT, C, TE, STR, GM 
138 20 F&R - D R S S83L –– B1 58 155 AM, SXT, TE, STR 
50 24 F&R - D R R S83L, D87N –– A 10 10 AM, SXT, C, TE, STR 
57 25 F&R - D R R S83L, D87N –– A 744 –– AM, SXT, C, TE, STR, K 
60 25 F&R - D R R S83L, D87N –– A 744 –– AM, SXT, C, TE, STR, K 
105 70 F&R - D R S S83L –– B1 847 –– AM, SXT, STR, K 
98 72 F&R - D R R S83L, D87N –– B1 297 –– AM, CTX 
104 72 F&R - D R R S83L, D87N –– B1 new –– SXT, TE, GM 
82 52 FF - D R R S83L, D87N –– B1 1431 –– SXT 
87 54 FF - D R S S83L –– C 88 23 AM, SXT, TE, STR, K 
153 57 FF - D IR S –– qnrB B1 99 –– TE, STR 
133 61 FF - D R S S83L –– A 93 168 –– 
95 67 FF - D R S S83L –– B1 737 –– SXT, TE, STR 
112 78 M&G - D R R S83L, D87N –– C 90 23 AM, SXT, TE, STR, GM 
32 14 F&R - W R S S83L –– C 88 23 AM, SXT, STR, K 
33 14 F&R - W R S S83L –– C 88 23 AM, SXT, STR, K 
48 20 F&R - W R R S83L, D87N –– A 2197 –– AM, SXT, C, TE, STR, GM 
51 20 F&R - W R R S83L, D87N –– B1 297 –– TE 
52 20 F&R - W R R S83L, D87N –– B1 297 –– TE 
46 24 F&R - W R R S83L, D87N –– A 10 10 AM, SXT, C, TE, STR 
140 70 F&R - W IR S –– –– F 117 –– –– 
120 76 F&R - W R S S83L –– C 23 23 –– 
61 35 FF - W R S S83L –– B1 847 –– SXT, TE, STR, GM 
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70 35 FF - W R S S83L –– B1 new –– SXT, TE, STR 
162 35 FF - W IR S –– qnrS A 227 10 TE, STR, K 
76 47 FF - W R S S83L –– A 898 –– TE, STR 
74 50 FF - W R R S83L, D87N –– B1 297 –– TE 
78 50 FF - W R R S83L, D87N –– A 2509 –– AZM, TE, STR 
80 50 FF - W R R S83L, D87N –– B1 297 –– TE 
81 52 FF - W R R S83L, D87N –– B1 297 –– TE 
86 54 FF - W R S S83L –– C 88 23 AM, SXT, TE, STR, K 
89 58 FF - W R S S83L –– B1 58 155 SXT, TE, STR 
91 63 FF - W R S S83L –– C 88 23 AM, SXT, STR, K 
90 65 FF - W R R S83L, D87N –– B1 297 –– TE 
94 66 FF - W R R S83L, D87N –– B1 297 –– TE 
172 68 FF - W IR S –– qnrB A 993 –– TE, STR 
147 7 M&G - W IR IR –– qnrB + qnrS A 10 10 AM, SXT, TE, STR, GM 
148 7 M&G - W IR S –– qnrB + qnrS A 10 10 AM10, SXT, TE, STR, GM 
174 78 M&G - W IR S –– qnrB B1 3322 86 AM, STR, GM 
36 14 F&R - SL R S S83L –– F 117 –– AM, SXT, C, TE, STR 
37 14 F&R - SL R R S83L, D87N –– A 2197 –– AM, SXT, C, TE, STR, GM 
47 24 F&R - SL R R S83L, D87N –– A 10 10 AM, SXT, C, TE, STR 
58 25 F&R - SL R R S83L, D87N –– A 744 –– AM, SXT, C, TE, STR, K 
68 33 F&R - SL R R S83L, D87N –– A 2509 –– AM, TE, STR 
69 33 F&R - SL R R S83L, D87N –– A 2509 –– AM, TE, STR 
103 72 F&R - SL R R S83L, D87N –– A 10 10 AM, AMC, SXT, C, TE, STR, K 
151 35 FF - SL IR S –– qnrB B1 1665 –– K 
71 37 FF - SL R R S83L, D87N –– A 2509 –– TE, STR 
121 42 FF - SL R S S83L –– B1 1157 –– AM, SXT, TE, STR 
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75 45 FF - SL R S S83L –– C 88 23 AM, SXT, STR 
73 47 FF - SL R S S83L –– A 898 –– TE, STR 
77 47 FF - SL R S S83L –– A 898 –– TE, STR 
79 49 FF - SL R R S83L, D87N –– B1 297 –– SXT, TE, STR, K, GM 
72 50 FF - SL R R S83L, D87N –– A 2509 –– TE, STR 
170 50 FF - SL IR S –– qnrB B1 99 –– TE, STR 
83 52 FF - SL R R S83L, D87N –– B1 297 –– TE 
154 57 FF - SL IR S –– qnrS A 542 –– TE, STR, K 
84 58 FF - SL R S S83L –– C 88 23 AM, SXT, STR, K 
88 58 FF - SL R S S83L –– C 88 23 AM, SXT, STR, K 
171 63 FF - SL IR S –– qnrB E 524 32 –– 
93 64 FF - SL R R S83L, D87N –– B1 453 86 AM, SXT, TE, STR 
92 65 FF - SL R S S83L –– C 88 23 AM, SXT, STR, K 
131 68 FF - SL R S S83L –– A 93 168 –– 
111 77 FF - SL R R S83L, D87N –– B1 1196 –– AM, SXT, C, TE, STR 
134 77 FF - SL R S S83L –– A 10 10 AM, C, STR 
159 8 M&G - SL IR S –– qnrB A 4429 –– STR 
16 9 M&G - SL R R S83L, D87N –– A 10 10 AM, SXT, C, TE, STR 
17 9 M&G - SL R R S83L, D87N –– C 410 23 TE 
18 10 M&G - SL R S S83L –– A 6593 165 STR 
142 10 M&G - SL IR S –– qnrB A 48 10 STR 
110 78 M&G - SL R R S83L, D87N –– C 90 23 AM, SXT, TE, STR, GM 
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AM, ampicillin; AMC, amoxicillin with clavulanic acid; AZM, azithromycin; C, chloramphenicol; CC, clonal complex; CIP, ciprofloxacin; CTX, 
cefotaxime; CZ, cefazolin; D, dust sample; F&R, farrowing and rearing farm; FEP, FF, fattening farm; cefepime; FM, nitrofurantoin; FOS, 
fosfomycin; GM, gentamicin; IR, intermediately resistant; K, kanamycin; M&G, mating and gestation farm; NAL, nalidixic acid; new, new 
combination of alleles (detailed in supplementary Table S1); PG, phylogenetic group; R, resistant; S, susceptible; STR, streptomycin; SL, slurry 
sample; SXT, sulfamethoxazole/ trimethoprim; ST, sequence type; TE, tetracycline; W, wipe sample; +, use of fluoroquinolone during study period 
2016; -, no use of fluoroquinolone during study period 2016; ––, absence of point mutation, gene, CC, or additional resistance. 
 
 
 Acknowledgements 
First of all, I would like to extend my sincere thanks to Prof. Dr. Dr. h.c. Roger Stephan for the 
opportunity to do this doctoral thesis at the Institute for Food Safety and Hygiene at the 
University of Zurich and for his highly esteemed support and advices during the process. 
Further I would like to thank Dr. Magdalena Nüesch-Inderbinen, Dr. Katrin Zurfluh and Nicole 
Cernela, who supported me in word and deed throughout the whole time. Without the 
possibility to work with the E. coli strain collection, that originated from a preceding study, this 
thesis would not have been realizable. Therefore, a further acknowledgement to Dr. Dolf 
Kümmerlen, PD Dr. Xaver Sidler and Dr. Seraina von Ah, who also provided further 
information belonging to the isolates. 
 
 Curriculum Vitae 
 
Vorname Name 
 
Patrick Kindle 
 
Geburtsdatum 22.09.1990 
Geburtsort Wetzikon, Zürich 
Nationalität Schweizer 
Heimatort  Bütschwil, St. Gallen 
08/1997 – 07/2003 
08/2003 – 07/2006 
08/2006 – 07/2009 
08/2010 – 07/2012 
Primarschule, Winterthur ZH, Schweiz 
Sekundarschule, Winterthur ZH, Schweiz 
Berufsbildungsschule, Winterthur ZH, Schweiz 
Kantonale Maturitätsschule für Erwachsene, Zürich ZH, 
Schweiz 
  
27.06.2012 Matura, Kantonale Maturitätsschule für Erwachsene, Zürich ZH, 
Schweiz 
  
09/2012 – 07/2017 Studium der Veterinärmedizin, Universität Zürich, Zürich, 
Schweiz 
  
29. 12. 2017 Staatsexamen vet. med., Universität Zürich, Zürich, Schweiz 
  
03/2018 – 01/2019 Anfertigung der Dissertation  
 unter Leitung von Prof. Dr. Dr. h.c Roger Stephan 
 am Institut für Lebensmittelsicherheit und –hygiene 
 der Vetsuisse-Fakultät Universität Zürich 
 Direktor: Prof. Dr. Dr. h.c Roger Stephan 
 
